戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 less optimal learning on average within each age group.
2 eived comparatively little attention in this age group.
3 esults were similar by country but varied by age group.
4 predictive value of screening mammography by age group.
5 ts nationally and separately by state and by age group.
6 ot significantly vary by race, ethnicity, or age group.
7 ated well with stage of KC in this pediatric age group.
8 s that becomes more pronounced at the oldest age group.
9           Risk factors varied by species and age group.
10 opment and neuropsychiatric outcomes in this age group.
11 ctability of GRS in disease severity in each age group.
12  2013-2016 that was most evident in the >=65 age group.
13 not significantly differ by drug within each age group.
14 cantly more common with dapagliflozin in any age group.
15 ulating recommendations for each outcome and age group.
16 tes for both sexes being observed in the 95+ age group.
17 able population-based IFR estimates for this age group.
18 ing asthma, of which little is known in this age group.
19  and most commonly in the 20- to 40-year-old age group.
20 ere morbidity and mortality from RSV in this age group.
21  in order to design better vaccines for this age group.
22 t with historical experience of PCVs in this age group.
23 of other NVTs are affecting each country and age group.
24 r VI increased significantly with increasing age group.
25  offers a valuable treatment option for this age group.
26 r primary safety outcome by drug within each age group.
27 he local drift values were below zero in all age groups.
28 1.73) compared with non-IC patients in those age groups.
29  similar magnitude of the effects in the two age groups.
30 n 0.75 and 0.97 and exceeded 0.83 in 8 of 10 age groups.
31 ions with a great variation across different age groups.
32 genotypic diversity varied amongst different age groups.
33 howed more feedback sensitivity than younger age groups.
34 nificantly associated with mortality between age groups.
35 lity were higher in men than in women in all age groups.
36 th region of the visible spectrum across all age groups.
37  the centre of the object was found for both age groups.
38  0-15 (117/242; 48%) and 16-30 (89/242; 37%) age groups.
39 n <5 years of age, but 28F increased in both age groups.
40 ating social distancing applied to differing age groups.
41  allow robust subgroup analysis in the older age groups.
42 n VE between seasons, influenza strains, and age groups.
43 ded illnesses, and hospitalizations across 5 age groups.
44 an 2, but the reverse was seen for all other age groups.
45 between fatal and nonfatal cases across both age groups.
46 y distinct between spinal laminae and across age groups.
47 4, 3.08-3.19, p < 0.001) compared with other age groups.
48 ent in children to compare outcomes in three age groups.
49 stics were balanced across treatments within age groups.
50 of the human nasal microbiota from different age groups.
51 ontrol increased from 1999 to 2016 among all age groups.
52 d duration of unique infections according to age groups.
53 st probability estimates across most sex and age groups.
54 rs whose crash rate is the highest among all age groups.
55 xa consistently gained in disease across all age groups.
56 f England (excluding London) for all sex and age groups.
57  are increasing, driven primarily by younger age groups.
58 imal test protocol of VO(2max) for different age groups.
59 n 0.56 and 0.89 and exceeded 0.68 in 8 of 10 age groups.
60 and therapeutic strategies for people of all age groups.
61 year and 71.2% (41.0 - 85.9) in 12 - 16 year age groups.
62 t carriage of these serotypes remains in all age groups.
63  during learning from trial and error across age groups.
64 elated shift in the clinical features across age groups.
65 ey measures varied widely across surveys and age groups.
66 creased over the past two decades across all age groups.
67 d be avoided in men compared to women in all age groups.
68  been observed to vary between congeners and age groups.
69 -2 months) as well as the older (7-8 months) age groups.
70 issue after LPS challenge was delayed in the aged group.
71 ring post-IRS to pre-IRS incidence rates for age groups 0-3, 3-5, and 5-11 were 0.108 (95% confidence
72                   Outcomes were compared for age groups: 0-<3, 3-<6, 6-<12 months, and 1-<3 years (Gr
73      The participants were divided into nine age groups: 0-2 months, 3-6 months, 7-9 months, 10-12 mo
74           Myopia was more common among older age group 17-21 years (OR: 1.54 95% CI 0.986-2.415) and
75                    On Multivariate analysis, age group 18-30 years, discharge against medical advice,
76                     Patients were split into age groups (18-49, 50-54, 55-59, 60-64, 65-69, >=70), an
77                                  In the same age groups, 2-dose VE was 78% (IRR, 0.22; 95% CI, .18-.2
78 al of 96 participants were divided into four age groups (22-24, 30, 40-41, and > 48 years of age) and
79 s significantly higher in the 14- to 17-year age group (24.7%, P = 0.041; 25.8%; P = 0.001) compared
80             Healthy children in one of three age groups (24-59 months, 12-23 months, and 6-11 months)
81                                       Across age groups 25 y and older, excess mortality was negative
82 rcentage change in incidence rates by 5-year age group (25-29 years to 80-84 years in 5-year incremen
83 were derived from NOD mice of three distinct age groups (3, 8 and 18-week-old).
84        Predictors of HAV susceptibility were age group 30-49 years, non-Hispanic white/black, 130% ab
85                                          The age group 31-35 years had the highest frequency of infer
86  different cutoff values were calculated for age groups 4-10 and 11-18.
87 PV leaflets from porcine hearts in different age groups (~ 4-6 months, denoted as young versus ~ 2 ye
88 lve durability on life expectancy in younger age groups (40, 50, and 60 years).
89 erformance decreases with age (C indices for age groups 45-54, 55-64, 65-74, 75-84 are 0.75, 0.72, 0.
90  above the 80th percentile within each of 10 age groups (5-y intervals between 30 and 74 y as well as
91 ith stage 2 tumors had a reduced EFS in both age groups (5-year EFS +/- SD, 84% +/- 3% in patients <
92 ns [1-3], robust across paradigms [1, 4] and age groups [5-7].
93 as dominated by vaccination with RZV for all age groups 60 years or older.
94 he 10 years between CSS0 and CSS5 across all age groups (67.6% to 13.5%, p<0.001; 59.8% to 14.4%, p<0
95 ne epsilon4 allele was greatest in the 65-70 age group (69.7%) and weaker before 55 years (14.2%) and
96 ection fatality rate (IFR) estimates for the age group 70 years older are still scarce.
97                           Crucially, in both age groups, a more responsive noradrenergic system was s
98                          COVID-19 IFR in the age group above 69 years is estimated to be 65 times as
99 ts and has similar immunogenicity across all age groups after a boost dose.
100 BC cases compared with controls in the young age groups [age 26-52 (P = 0.0025) and age 22-46 (P = 0.
101 nds were also similar by stratum of baseline age groups (all p for interaction < 0.001).
102 bust but subtle differences across different age groups among ADHD, ASD, and OCD.
103 patient characteristics and mortality across age-groups among COVID-19 inpatients.
104 ventive treatment of malaria to protect this age group and advance the goal of malaria elimination, w
105 34% of all rectal cancer cases, depending on age group and calendar year.
106 edominantly seen among the younger pediatric age group and current interventions targeted for those <
107 ated the presence of effect heterogeneity by age group and employment status.
108 s for domestically acquired salmonellosis by age group and FoodNet site to help focus prevention effo
109 s for domestically-acquired salmonellosis by age group and FoodNet site to help focus prevention effo
110 3 mum to 191.13 +/- 13.83 mum in the younger age group and from 251.33 +/- 26.60 mum to 197.08 +/- 17
111 V-uninfected females 12-24 years, matched by age group and number of lifetime sexual partners.
112  opioid use disorder in the United States by age group and sex using a national prescription database
113 tentional (assault and suicide) injuries, by age group and sex.
114 in the baseline year (2017), split by 1-year age group and sex.
115 y-confirmed influenza hospitalization in all age groups and a decrease in illness-specific school abs
116 Type 3 seroprevalence was below 75% for both age groups and areas.
117 ing time from surgery and was similar across age groups and calendar time.
118 sthma and wheezing in cohorts with different age groups and could be used in asthma phenotyping.
119 most common indication for biopsy across all age groups and genders.
120 ad in many parts of the world, affecting all age groups and increasing with age. It is primarily due
121 efficacy of this vaccine is warranted in all age groups and individuals with comorbidities.
122 in fitting to past trends in NVT IPD in some age groups and inherent uncertainty about future NVT beh
123      LP significantly delayed the IPI in all age groups and may allow for longer preservation periods
124 chanisms of exercise may be universal across age groups and populations versus those that might be di
125 y in the association by wealth quintiles and age groups and present country-specific estimates.
126 c differences were observed across different age groups and surface area differences among all disord
127 ss of HCV treatment in patients of different age groups and to estimate the price at which DAAs becom
128 ncrease in mortality risk was present in all age groups and was greatest in those diagnosed in the ag
129 ng-term quitters, 22% (19-25) in the younger age group, and 23% (22-24) in the USPSTF group.
130 t 3-month follow-up adjusted for sex, 5-year age group, and general practice.
131 ptoms varied by season, geographical region, age group, and sex.
132    Rates were higher among males, in younger age groups, and among white PLWH.
133 ries with low child mortality, among younger age groups, and in countries with higher coverage.
134  in the nucleus accumbens was similar across age groups, and numerically higher in older adults.
135 outes and its variability between chemicals, age groups, and subpopulations, by modeling aggregate hu
136  be increasing in some racial/ethnic groups, age groups, and US regions.
137 sion was comparable with that of the younger age group, apart from cardiovascular and renal dysfuncti
138 an women and children is nonnegligible; some age groups are disproportionately affected.
139 as no difference in risk of AEs in the 18-49 age group (aRR 0.93 [95% CI 1.48-0.75] p=0.75).
140 r generator and with stratification based on age group at onset of symptoms.
141 al residents by 3- to 6-fold in each 10-year age group between 18 and 59 years (P < 0.001 comparing v
142  adults with IDU histories, we compared sex, age group, birth cohort, race/ethnicity, health insuranc
143  leukemia (ALL), but risk differences across age groups both in relation to first-time AAP and after
144  was positive in the 65- to 79- and >= 100-y age group but not significant and positive in the other
145 ootprints were made by a mixed-sex and mixed-age group, but one that consisted of mostly adult female
146               The cohort was divided into 16 age groups by sex.
147  with DMD versus control participants in all age groups by using quantitative T2 MRI (P < .001) and (
148 commonly affects newborns, infection in this age group can be devastating.
149 e, such as France, whereas confining younger age groups can have a greater impact in countries with l
150  of Bavaria, 3.5 million inhabitants in this age group) can participate in the program between Octobe
151 ociated with lower cognitive z scores across age groups (children < 5, beta -0.42, 95% CI, -0.69 to -
152  rest in 105 participants divided into three age groups: children (6-9 years), young adults (18-34 ye
153  cells were similarly expanded across all AD age groups compared with control subjects (P < .05).
154 e pharmacokinetic sampling conducted in each age group confirmed the appropriateness of sofosbuvir do
155  and fluorescence in-situ hybridization in 2 age groups (cutoff age, 18 months) and were quality cont
156                     Pneumonia deaths in this age group decreased from 1.7 million (95% UI 1.7-2.0) in
157         Selecting appropriate seromonitoring age groups depends critically on age-dependent exposure
158   Pressure measurements were not affected by age group, donor-recipient size differences, or ischemic
159  and the number of injections needed in each age group during the study period.
160 hildren) could classify diagnosis in another age group (e.g., adults).
161 f connections that classify diagnosis in one age group (e.g., children) could classify diagnosis in a
162 measures by age-group, fitted trend lines to age-group estimates, and used the trend-line equations t
163 significantly increased regardless of sex or age group except among subjects 80 years or older, and i
164 significantly increased regardless of sex or age group except among subjects 80 years or older, and i
165 macy was more frequent among PLWH across all age groups except those aged >=75 years and was more com
166 der women in both rural and urban areas, all age groups experienced similar increases.
167     Significant trade-offs in the 45-49-year age group explain the overall difference between hypothe
168 care seeking was highest for the <18 and 65+ age groups, females had a greater percentage compared wi
169 mate the central tendency across measures by age-group, fitted trend lines to age-group estimates, an
170 -2003 model years) accounted for the largest age group for both.
171 ce was between 18 and 40 years, but the peak age group for health care expenditures was those older t
172 ence increased significantly with increasing age group for summarized survey responses but not for NH
173 ls can help to identify the most informative age groups for serological monitoring and investigate th
174  was used to assess (1) the most informative age groups for serological monitoring using receiver ope
175 ) from cardiovascular diseases for different age groups for these countries.
176 ncidence rates have continued to increase in age groups for which HZ vaccines are not currently recom
177 19, SEAP recruited study participants of all age groups from its outpatient, inpatient, hospital labo
178                    Current omission of these age groups from treatment and monitoring exacerbates hea
179 he IR of HZO was calculated by year, 10-year age groups, gender, race, and region.
180   We stratified meta-analyses by participant age group, geographical region, and residence in rural o
181 ncidence in specific anatomic sites for this age group has impeded prevention and early detection pro
182   An increasing share of the most productive age groups has an additional positive effect on economic
183 iasis control in sub-Saharan Africa, several age groups have been eclipsed by current treatment and m
184         Therapy was equally effective across age groups, HIV status, and International Prognostic Ind
185  reference memory were not different between age groups; however, older animals compensated for impai
186 SSBs had on obesity incidence across various age groups in Portugal.
187 the curve of the models exceeded 0.85 in all age groups in the DC and 0.84 in the VC, indicating well
188  glutamate release was elevated in all three age groups in the DG, but temporally delayed to 18-20 mo
189  and 5.7% and 5.8%, respectively, in these 2 age groups in the SMC villages, with prevalence differen
190               Complications were seen in all age groups, including patients born after the Early Trea
191           The prevalence of myopia among all age groups increased steadily.
192                                   Later life age groups independently from their sexual orientation r
193 antial proportion of clinical illness across age groups, irrespective of HIV status.
194  are most affected by periodontitis in their age group is currently unavailable.
195  cell transplantation (HCT) in the pediatric age group is lacking.
196  doses on clinical endpoints in the targeted age group is warranted.
197                                 In the above age groups, it was 87.9%; 91.4%; 89.6%; 86%; 76.3%; 71.3
198 at the age distribution of deaths in younger age groups (less than 65 years of age) is very consisten
199  PCV10 on monthly case counts by outcome and age group (&lt;1 year, 1-4 years), accounting for seasonali
200 er, using Bayesian methods and stratified by age group (&lt;18 years, 18-65 years, and >65 years), to le
201 a minimisation algorithm based on centre and age group (&lt;40 years vs >=40 years).
202           Insomnia was associated with young age group (&lt;=25 years) (odds ratio (OR) = 2.20, 95% conf
203         Insomnia was associated with younger age group (&lt;=25 years), higher anxiety level, and poor s
204              Results were also stratified by age groups (&lt;50 years, 50-69 years, or 70-90 years).
205                  The cohort was divided into age groups: &lt;=2, 3 to 5, 6 to 8, 9 to 11, 12 to 14, 15 t
206 ted "salutary sheltering" by 50% of a single age group may substantially curtail transmission when co
207 s after a boost dose were similar across all age groups (median MNA(80) at day 42 in the standard-dos
208                Compared to women in the same age groups, men's mortality rates were particularly elev
209 ecrements were significant only in the older age groups (mild-moderate VI: 6.2% and 8.1% reduction in
210 ascular events were observed in the youngest age group modeled (35-44 years) for both men and women;
211 evalence were noted in both sexes and across age groups-most notably in women and girls aged 16-24 ye
212     To address the challenges unique to this age group, novel strategies to provide the best preopera
213 26.62 +/- 3.93 years) within the gestational age group of 13 to 32 weeks participated in this cross-s
214 revalence measures of mortality for multiple age groups of mothers in 20 sub-Saharan African countrie
215                        Lymphomas afflict all age groups of people, with certain types demonstrating a
216 he unidimensional task did not differ across age groups, older adults performed worse than younger ad
217 arity and memory performance differs between age groups: Older adults benefited from higher similarit
218 OVA revealed a significant overall effect of age group on metabolite levels in all regions.
219 e the role of transmission due to particular age groups on total infections and deaths.
220 uenza vaccination were derived from a single age group or season, ignoring the effects of immunosenes
221    Other pathogens were important in certain age groups or sites.
222 , twice the percentage of cases for the same age group outside of prison.
223 .60 mum to 197.08 +/- 17.64 mum in the older age group (p = 0.001).
224               CNV was smaller in the younger age group (p-value 0.209), best corrected visual acuity
225 e interval, 0.09-0.67]; P = 0.007) and older age groups (P = 0.017).Conclusions: Severe TBI in older
226 o 2.41; p < 0.001), as was the case in older age groups (p interaction = 0.54).
227  of stigma and violence were similar between age groups (p>0.05).
228 roved significantly in the younger and older age groups (p-values 0.001 and 0.028, respectively), and
229 ruited to a low-dose cohort, and within each age group, participants were randomly assigned to receiv
230 ased rates of discontinuation included adult age group, percent predicted FEV(1) (ppFEV(1)) less than
231 ile female ophthalmologist across almost all age groups, practice categories, and geographic regions.
232                                       In all age groups, pregnancy incidence rates were highest in wo
233 reasing trends in some states and in younger age groups, primarily among black PLWH.
234 r changes in inflation, population size, and age groups, public insurance spending was estimated to h
235 age gHFI and average sM burden in increasing age groups (r = -0.70, P = 0.017).
236 average number of sM increases in increasing age groups (r = 0.92, P = 0.000073).
237                                              Age group, race, and gender were included as covariates
238 erson-years), with little variation in older age groups (range, 7 to 11 per 100 person-years).
239 erformed in volunteers stratified into seven age groups ranging from 11 to 88 years.
240 is and extra-pulmonary pathologies, and both age groups recovered in two weeks.
241  tetravalent dengue vaccine suitable for all age groups, regardless of serostatus.
242 ar (4.6%; 4.6%), and 2- to 5-year (8.3%; 0%) age groups, respectively.
243         Particle emissions varied across the age groups: seniors (average age 70.5 years) generated 5
244                   In 3 studies stratified by age groups, sensitivity of CRC detection was 85% for age
245 ID-19" in current guidelines) by age (5-year age groups), sex, and country for 188 countries using pr
246 r differences in non-response rates based on age group, sex, and census-tract income.
247 emographic and regional subgroups, including age group, sex, census region, and place of care using a
248            Sepsis-related mortality for each age group, sex, location, GBD cause, and year (1990-2017
249 Event rates were stratified by ethnic group, age group, sex, socioeconomic status, and time period (<
250 ng estimates stratified by health condition, age group, sex, type of care, and type of payer and mode
251 dence rates were calculated by year, 10-year age groups, sex, and race/ethnicity.
252 t the full criteria for type 2 diabetes with age group-, sex-, encounter type-, and diagnosis date-ma
253                               People in this age group should be discouraged from using alcohol as a
254 duals, and, across cases and controls, older age groups showed more feedback sensitivity than younger
255 ision impairment and oral health outcomes by age group, sociodemographics, and other explanatory vari
256        We obtained 2015 country-specific and age-group-specific asthma incidence rates from the Insti
257  cortex was inversely related to ELT in both age groups, such that individuals with more ELT demonstr
258 es were increased in patients with AD in all age groups, suggesting systemic immune activation with d
259 tely but expressly did not generalize across age groups, suggesting that the patterns of functional c
260 tal OH reactivity was observed for different age groups (teenagers/young adults/seniors) without ozon
261 e Cervex-Brush and Cytobrush/spatula for all age groups tested.
262  For validation, we predicted PID rates in 4 age groups that agree well with surveillance data.
263 ry infection and diarrhoea, respectively, in age groups that experience the greatest disease burden a
264 [CI], 0.19 to 0.36), with a 75% reduction in age groups that were fully eligible for vaccination.
265                       Per each 10-year older age group, the average RNFL thickness was 2.5 mum (95% c
266                                      In this age group, the estimated distant recurrence at 9 years e
267                                       Within age groups, the best agreement was found in those aged 5
268                         We show that, across age groups, the dominant error source is unbiased noise
269 16.5%, 95% CI 14.7-18.4) was similar in both age groups, the majority of whom received their method f
270 ased more steeply than adenocarcinoma in all age groups, thus affecting the contribution of carcinoid
271 rocedure 1 [P1], 2 [P2] and 3 [P3]) for each age group to quantify VO(2max).
272                       The inclusion of elder age-groups to the low-risk programme typically lessened
273 dial artery diameters in children across all age groups, to establish reference ranges for clinical u
274 vide estimates of bereavement multipliers by age group, types of kin loss, and race to illuminate pro
275 g water and children's BLLs, and (2) in some age groups, under realistic local and residential water
276 idemiology of NTM infection in the pediatric age group using data from the UK CF Registry.
277 idence intervals for each survey measure and age group using the Clopper-Pearson method.
278  effect of limiting contacts by a particular age group varies by location, indicating that strategies
279  (per 100 person-years, placebo arm) in each age group was 13.6 (95% CI, 10.4-17.9), 15.7 (95% CI, 13
280 ncreased imaging duration (350 s) across all age groups was shown to be acceptable.
281  to be differentially expressed across three age groups, we identified one candidate (miR-216a) impli
282 e exact amount of SSBs consumed by different age groups, we modeled 2 estimates of baseline consumpti
283 n of TB, and treatment outcomes in different age groups were compared.
284                                          Two age groups were included to compare MCV2 coverage pre-MA
285            The small differences between the age groups were nullified by the use of LP.
286 h rates (standardized by population size and age group) were calculated for each type of payer and he
287     Men had a higher incidence rate for most age groups when compared to women.
288 is study aims to identify the optimal target age groups when extending a seasonal influenza vaccinati
289 lt in prolonged and fatal illness across all age groups, which has been attributed to the overt and u
290 reases were seen among men; middle and older age groups; whites, blacks, and Hispanics; and the socio
291 on of preterm infants across all gestational age groups who achieved protective IgG antibody levels a
292 th NASH were similar to patients of the same age group with ALD or HCV.
293             Adults aged 20-25 years were the age group with the highest odds of receiving part (OR 1.
294 ot significant and positive in the other two age groups with similar results.
295  genes correlated with spatial memory across age groups, with a greater number in region CA1.
296 ociation by 3 control groups and 3 follow-up age groups, with data from studies published between Jan
297 higher among males, than females, across all age groups, with the highest rates for both sexes being
298 tions, and obesity were risk factors in most age-groups, with highest relative risks among 20-39 year
299 Disease onset in females occurred across all age groups, without any comparable dramatic peak of onse
300 ent avoiding primary infections for specific age groups would prevent subsequent deaths due to within

 
Page Top